



Maternal and Fetal Effects
VERN L. KATZ, MD; JEFFREY A. KULLER, MD; MICHAEL J. McMAHON, MD; MARTHA A. WARREN, RN;
and STEVEN R. WELLS, MD, Chapel Hill, North Carolina
To determine the characteristics of maternal varicella at our institution, we reviewed all cases of pri-
mary varicella in pregnancy. Using a perinatal database that summarizes all obstetric admissions, we
reviewed the medical records of women with varicella infections during pregnancy. Over a 5%4-year
period, 31 pregnancies were affected by varicella infection among 11,753 deliveries. The mean age of
those patients was 19.6 years, significantly different from our overall population of 25.3 years (P <
.05). The racial composition of 35% Hispanic, 35% white, and 29% African American was different
from that of our general population of 55% white, 38% African American, and 6% Hispanic (P= .023).
The mean gestational age of the eruption of vesicles was 25 weeks. Of the 31 women, 7 had preterm
labor within a week of their varicella, 3 delivered prematurely, and 3 infants had a birth weight of less
than 2,700 grams. Respiratory symptoms developed in 6 women, and pneumonia developed in 4, 2
of whom required ventilatory support, 1 for 5 days, the other for 49 days. Eight women received acy-
clovir during gestation, and none suffered sequelae. In all, 6 infants had lesions and anomalies noted
at birth, 5 possibly associated with varicella.
Varicella infection is associated with a greater-than-expected level of both maternal and fetal mor-
bidity. The fetal disease may occur due to maternal infection at any gestation and is most likely a spec-
trum of complications. The maternal disease appears to be worse in the latter half of pregnancy.
Programs of prevention through vaccination must account for a possibly decreased level of immunity
in different populations.
(Katz VL, Kuller JA, McMahon MJ, Warren MA, Wells SR: Varicella during pregnancy-Maternal and fetal effects. West
J Med 1995; 163:446-450)
Varicella infection in pregnancy has possibly devas-
tating consequences for both women and their fetus.
The overall incidence of varicella in pregnancy has been
estimated from 1 to 5 per 10,000.'2 Although it is a rela-
tively benign disease in early childhood, the complica-
tions, both fetal and maternal, present several manage-
ment problems for clinicians. Several issues regarding
varicella in pregnancy are still debated, such as the spec-
trum and degree of fetal manifestations, the incidence
and severity of varicella pneumonia, and the use of
antiviral agents. Some authors have suggested that the
rate of fetal manifestations is low if the maternal infec-
tion occurs more than a week from delivery, whereas oth-
ers have reported a wide spectrum of fetal involvement.3
The use of varicella-zoster immune globulin vaccine for
chickenpox when maternal infection occurs within five
days of delivery is an established practice, but the effec-
tiveness of its use in preventing fetal disease is incom-
plete at best."4 The use of acyclovir for the treatment of
maternal chickenpox is also an area of discussion. Some
investigators recommend treatment of any pregnant
patient with varicella, but others recommend using the
drug only for varicella pneumonia.2 -8 Data are incom-
plete as to the use and indications of antiviral agents.
Recent admissions to our obstetric service of women
with chickenpox and its subsequent morbidity led us to
review the effects of this disease during pregnancy.
Patients and Methods
We reviewed the medical records for the period
January 1989 through July 1994 of all patients admitted
to the obstetric service at the University of North
Carolina Hospital, Chapel Hill, both delivered and unde-
livered, who had chickenpox in pregnancy. All diag-
noses were made clinically. The University Hospital is a
tertiary-level referral center that cares for both a public
and private population. It is the policy of the University
Hospitals that all pregnant women be admitted to the
obstetric service regardless of diagnosis. On discharge
from the hospital, all obstetric patients' records are eval-
uated by a specially trained obstetric technician who
records them in the perinatal database. All records are
then reviewed by a senior perinatologist. Varicella is
coded for specifically. Thus, if a woman had chickenpox
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in pregnancy, even if she was not admitted for that diag-
nosis, the event would be noted and her medical record
could be retrieved.
Using a MEDLINE search with manual cross-
reference, we reviewed recent literature regarding vari-
cella, zoster, and chickenpox infections in pregnancy.
Statistical analysis was performed with Fisher's exact
test and t test with unequal variance. A P value of less
than .05 was considered significant.
Results
From January 1989 through July 1994, there were 31
cases of pregnancy complicated by chickenpox infection
on our obstetric service (Table 1). There were 32 live-
born infants delivered (1 set of twins) and no cases of
fetal demise. During this time period, 11,753 women
were brought to delivery. Of the 31 women with chick-
enpox, 3 were referred from other institutions and 4
women delivered at other hospitals. The mean age of
patients was 19.6 years ± 4.3 (1 standard deviation;
range, 15 to 33 years).
Chickenpox developed in 11 women at 24 weeks or
less. The mean date of delivery was 39 weeks (range, 35
to 42 weeks). Four women had delivery at less than 37
weeks. All four of these patients delivered within a week
of the eruption of vesicles. Of the 32 infants, 3 had birth
weights of less than 2,700 grams, and 3 infants had birth
weights of less than the 10th percentile for their gesta-
tional ages. Two of the mothers of these three small-for-
gestational-age infants had prenatal care starting late in
their pregnancy: 19 and 27 weeks' gestation. The other
had no specific risk factors for premature delivery. The
smallest infant was 2,500 grams at 41-plus weeks. Three
infants received acyclovir at birth for 14 days of therapy.
The contacts for infection were documented in 10 of 31
patients, and all but 1 of the contacts were immediate
family members.
Other than the preterm deliveries, five women had
obstetric complications. There were three cases of
preterm labor successfully managed with tocolysis. All
three of the preterm labor episodes occurred within a
week of the eruption of vesicles, and none of these
women had histories of preterm labor. Thus, 7 of the 20
women (35%) who had infection after 24 weeks had
preterm labor associated with their varicella. Although
the rate of preterm labor in our population is 15.2%, we
cannot compare the rates because of the referral nature
of our population at a tertiary-care center. Another
woman (3%) had third-trimester bleeding not related
temporally to her chickenpox; 1% of our population has
third-trimester bleeding. Preeclampsia developed in one
woman, also distant from her varicella infection; 7% of
our population is diagnosed with preeclampsia. We do
not think that these last two complications were related
to the varicella infections.
Of the 31 women, 6 had respiratory symptoms. Two
women had dry coughs, symptoms of chest tightness,
and mild tachypnea. They had no evidence of pneumon-
ic involvement on chest x-ray films, and both had nor-
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mal arterial blood gas measurements. One of the women
was administered intravenous acyclovir for seven days,
and the other was managed expectantly. Two other
women had chest film findings suspicious for varicella
pneumonia, in addition to having nonproductive coughs.
Respiratory compromise did not develop in either of
these patients, and after inpatient observation, both were
discharged to home without sequelae. One of these
women was treated for seven days with the administra-
tion of intravenous acyclovir. Severe varicella pneumo-
nia developed in two patients, with morbid courses. The
first, who was carrying a twin gestation at 23 weeks, had
shortness of breath and tachypnea five days after the
onset of her viral eruption. Intravenous acyclovir thera-
py was started, but her pulmonary status deteriorated
and she required ventilatory support. She remained on a
ventilator for five days and was an inpatient for 16 days.
Her pulmonary recovery was unremarkable, and her
twins were delivered at 38 weeks, appropriately grown
and without evidence of congenital varicella.
The last patient, a 25-year-old gravida 3 para 1, had
a varicella rash develop at 16 weeks of gestation. Her
shortness of breath evolved 36 hours after the appear-
ance of vesicles. The patient's respiratory status rapidly
declined, and she was intubated four hours after admis-
sion. While receiving 100% oxygen before intubation,
the patient's Po2 was 70 mm of mercury, Pco2 32 mm of
mercury, pH 7.37, respiratory rate 48 breaths per minute,
and saturation 94%. Treatment with intravenous acy-
clovir was begun, and a dopamine drip was initiated 24
hours later for decreased urine output. Secondary adult
respiratory distress syndrome developed, requiring high
ventilator settings. The patient continued to have a frac-
tion of inspired oxygen of greater than 85% for four
weeks. A tracheostomy was done at week 4. During the
patient's second week on a respirator, staphylococcal
sepsis developed, and in her fifth week in the hospital,
Pseudomonas aeruginosa sepsis developed. Both were
managed successfully with antibiotic therapy. She
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and recurrent pneumothoraces. Parenteral nutrition was
given from 18 to 25 weeks' gestation. The patient was
gradually weaned off the ventilator and extubated on
hospital day 49. The tracheostomy was capped on day
66. The patient was walking without oxygen by day 70.
She gradually recovered as an outpatient, and at 372
weeks, a 6-lb 8-oz male infant was delivered. Although
the infant had no skin lesions or evidence of central ner-
vous system involvement, he did have bilateral clubfeet.
Of the 31 women, 8 received acyclovir, and 2 other
women received zoster immune globulin. One woman
was given both. None of the 10 women had adverse
reactions from these drugs. Of the 32 infants, 6 (19%)
had anomalies. Two infants had skin lesions-old and
new vesicles-at delivery, none with associated limb
lesions or skin scarring. The maternal chickenpox in
these cases occurred at 34 and 38 weeks' gestation, and
one woman received zoster immune globulin during her
infection. One infant (mentioned earlier) had bilateral
clubfeet with maternal infection diagnosed at 16 weeks.
One infant had meningomyelocele and hydrocephalus;
maternal infection occurred at 25 weeks. One had a ven-
tricular septal defect with a patent ductus arteriosus,
necessitating neonatal digoxin therapy. This infant's
mother had varicella at 20 weeks. The last infant had
chronic respiratory difficulties for the first few months
of life, characterized as a reactive airways syndrome.
The mother of this infant had chickenpox at 24 weeks'
gestation and was treated with acyclovir.
Discussion
Several major issues need consideration in cases of
varicella in pregnancy: the effects of chickenpox on the
pregnancy; the incidence and severity of varicella pneu-
monia; the treatment and prevention of varicella infec-
tion in pregnancy, particularly with acyclovir; and the
effects of the infection on the fetus. These issues,
although the subject of several reports and data sets, are
still under discussion.
Our series and others in the literature indicate that
chickenpox has a detrimental effect on pregnancy out-
come. Seven women went into preterm labor within a
week of their infection, although only four delivered
premature infants. These women had varicella infections
late in the third trimester. In another report of 43 women
with varicella during pregnancy, 4 went into labor pre-
maturely.8 In a recent multicenter series of 106 pregnant
women with varicella compared with age-matched con-
trols, it was also found that the incidence of premature
birth was substantially increased among women with
chickenpox.9
Other authors have also reported cases of preterm
labor and delivery associated with chickenpox.6"' The
mechanism of the increased prevalence of preterm labor
is unknown. It is tempting to speculate on the production
of inflammatory mediators due to the viremia as being
related to the preterm labor, given recent reports of the
association of intrauterine cytokines and premature
labor. We found at least one other report of a case of
abruption in association with chickenpox.4
Several authors have suggested that either patients
with chickenpox may have a greater predilection of
pneumonia developing, or if pneumonia develops, it is
more severe during pregnancy.2',3 Others dispute this
and feel there is not an increased incidence of pneumo-
nia.5 In our series, the incidence was 13% (4 of 31).
Other authors report incidences of varicella pneumonia
between 9% and 16%."'15" There are many reports of
fatal varicella pneumonia occurring in all trimesters. It
appears that pneumonia developing later in gestation,
particularly in the third trimester, carries the highest
mortality.2'""6 Of the four cases of varicella pneumonia
in our series, the two patients requiring ventilation were
in their second trimester. In 1968, 18 cases of varicella
pneumonia in pregnancy were reported; it was this
report that first noted the severe prognosis of varicella
pneumonia in pregnancy.'4 In a review of 21 pregnancies
complicated by varicella pneumonia, 12 women
required ventilatory support, and 3 died.2 In two reviews,
one of 28 cases and another of 43, both described the
need for ventilatory support; some cases were fatal.8"' In
these and other reports, the authors suggested that there
is an approximate maternal mortality of 40% with vari-
cella pneumonia and recommended the use of intra-
venous acyclovir, suggesting that this may decrease
maternal morbidity and mortality.'2 Although our data do
not indicate whether pregnant women are at more risk
for pneumonia developing, we agree with most authors
that when pneumonia develops, it is more severe than in
nonpregnant adults.
Nonvaricella pneumonia during pregnancy may also
carry a higher morbidity and mortality compared with
that in nonpregnant women.",8 The graver prognosis
may be due to physiologic changes in immunity, altered
pulmonary function, and fluid volume shifts during
pregnancy. Many of the cases reported in the literature
involve the development of the adult respiratory distress
syndrome.
Most investigators concur that the use of intravenous
acyclovir sodium, 10 to 15 mg per kg a day, is helpful in
the management of varicella pneumonia. A higher dose
of acyclovir is needed for varicella infection versus her-
pes simplex because the varicella virus is ten times less
sensitive than herpes simplex to the effects of acyclovir.'5
Acyclovir inhibits viral DNA polymerase that is com-
mon to all the herpesviruses.15"9 The major side effects
from acyclovir are gastrointestinal upset, nausea, vomit-
ing, and a potential for nephrotoxicity.5"5"9 None of our
patients, and few patients in the literature, have experi-
enced difficulties with acyclovir.620 Its safety is well doc-
umented for use in pregnancy, and it does not appear to
be teratogenic. We support the position that in any preg-
nant patient with respiratory symptoms and chickenpox,
treatment with acyclovir should be promptly started.
Currently, however, there is no published evidence
that the use of acyclovir improves the outcome of
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patients with uncomplicated chickenpox.2' Chickenpox
pneumonia is extremely contagious. Thus, when possi-
ble, our patients who were admitted to the hospital were
put in negative-pressure rooms. Such rooms are certain-
ly not easily available on obstetric wards and particular-
ly in labor and delivery suites.
Our patient population appears fairly representative
of that of the southeastern United States. Although 85%
to 95% of adults in the United States are immune to vari-
cella, the growing population of Hispanic women in the
United States may create a larger proportion of patients
susceptible to this disease.9"' This finding has public
health implications. Other authors have suggested an
increased susceptibility to varicella in adults from sub-
tropical areas.' It is important that foreign-born persons
residing in the United States, as well as recent immi-
grants, be included if varicella vaccination programs are
to be effective.
Although the incidence of varicella in pregnancy has
been estimated to be 1 to 5 per 10,000 women,"2 we are
unsure why our incidence was approximately six times
higher. Our higher incidence is only partially explained
by referrals from other hospitals-3 of the 31 women.
Larger, multi-institutional databases may better explain
this finding.
The effects of varicella on the fetus is an area of con-
cern.9 The fetal involvement has been traditionally divid-
ed into three forms: "varicella embryopathy" stemming
from maternal disease occurring before 20 weeks' gesta-
tion; congenital varicella resulting from maternal infec-
tion from 20 weeks' gestation until term, but more com-
monly close to term; and neonatal disease occurring
when the pregnant patient has active lesions around the
time of delivery. Varicella embryopathy was first
described by Laforet and Lynch in 1947 and redefined by
several authors since.21-25 The embryopathy includes limb
hypoplasia, skin scarring, central nervous system involve-
ment, and other skeletal lesions."2' Although it is most
common before 20 weeks' gestation, the embryopathy
has been reported from infection as late as 26 weeks.3'2
The largest series of congenital varicella was pub-
lished recently.27 In that report, 1,373 pregnancies from
1980 to 1993 in the United Kingdom and Germany were
evaluated. The authors found that fetal disease occurred
most commonly between 13 and 20 weeks. Fetal anom-
alies varied from skin lesions to lethal multiorgan system
involvement. The use of zoster immune globulin in a
pregnant woman may not eliminate the incidence of vari-
cella embryopathy, but if given before maternal infection
develops, it may decrease or attenuate fetal disease.2' The
incidence of embryopathy appears to be between 2% and
3%.19'027 Investigators have emphasized that central ner-
vous system involvement from the varicella may lead to
deafness, cataracts, chorioretinitis, and microcephaly."2'22
If we define the embryopathy strictly as limb
hypoplasia, skin scarring, and central nervous system
lesions, there appears to be a low incidence of infection,
less than 3%.19'27 More likely the spectrum of viral mani-
festations is wider and merges with the syndrome
referred to as congenital varicella. Congenital varicella
may include skin, limb, and central nervous system
effects, but also includes organ involvement such as
blood, liver, and spleen.2'',",272 It may manifest itself as
a fulminant neonatal disease with maternal disease in the
third trimester or with maternal infection remote from
term.3'42527' In a recent review, it was emphasized that
the wide spectrum of clinical manifestations in a neonate
from maternal varicella included bowel obstruction, uri-
nary tract anomalies, and microtia.3
Perhaps the most interesting aspect of congenital vari-
cella is a theory advanced by Higa and co-workers.25
These authors have postulated that the skin lesions, limb
defects, and central nervous system lesions represent
zoster infections in utero and that the fetal effects of
varicella embryopathy are sequelae of repeated zoster
infections in the fetus, including in utero encephalitis.
This would explain many of the types of lesions and
also the frequent appearance of active vesicles when chil-
dren are born. Some infants with exposure to varicella
during gestation will have no lesions at birth, but zoster
will develop in the first two years of life, some will be
born with skin scarring, and others will have active
lesions.3'292 This theory also explains why the embryopa-
thy initially thought to occur before 20 weeks' gestation
has been reported at much later gestations. The theory
also links the specific anomalies seen with the embry-
opathy with the spectrum of lesions seen with the con-
genital varicella syndrome. Among our patients, it is
unlikely that the lesion in the infant with an open neural
tube defect was related to the mother's chickenpox. It is
difficult to find an association between the varicella
infection and the infant with reactive airways disease.
Clubfeet and ventricular septal defects have been previ-
ously associated with maternal varicella infection,327 but
these lesions are common.
It is difficult to draw controls from our population
because of the high referral rate of antepartum-diag-
nosed anomalies at our institution. Data from historical
controls yield incidences of as much as 1.2 and 2.5 per
1,000 live births, respectively.30 Similarly, hydro-
cephalus, meningocele, and patent ductus arteriosus are
not uncommon. Without direct virologic evidence of
varicella infection in the infants, we cannot say that
there is a causal relationship between an anomaly and a
maternal disease. Overall, in our series, 4 of 32 infants
had lesions. We agree that pure varicella embryopathy is
uncommon. We also concur with Higa and associates
that fetal disease is a spectrum and that infection after 20
weeks' gestation is not always benign.
Congenital varicella has been diagnosed antenatally
by ultrasound examination.3' Cranial anomalies, polyhy-
dramnios, hydrops, hyperechoic liver, hydronephrosis,
and clubfeet have all been visualized sonographically.
Prenatal diagnosis by umbilical blood sampling for
immunoglobulin M and polymerase chain reaction for
virus has also been reported.32 It is important to note that
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documented fetal infection does not necessarily mean
there will be fetal defects.8
Many clinicians are under the impression that zoster
immune globulin is effective for preventing chickenpox
in infants. It is given to an infant when its mother has
chickenpox within five days of delivery because there is
not sufficient time for immunity to develop and to be
transferred to the neonate. Varicella-zoster immune
globulin in the dose of 125 U per 10 kg is only 50%
effective in preventing the disease, although it may
decrease overall severity.' There are many reports in the
literature of chickenpox and congenital varicella, some-
times fatal, developing in infants despite the appropriate
use of this immunizing agent."433 Some authors have rec-
ommended increasing the dose to 250 U per 10 kg for
neonates because of the numerous reported failures with
125 units.34'5 Varicella-zoster immune globulin is not
indicated for pregnant women after varicella lesions
develop. Because of problems of obtaining titers in a
timely way and the general immunity in the population,
we do not routinely give this drug to a pregnant woman
after exposure to chickenpox. If a pregnant woman has a
known lack of immunity, however, its use would be an
appropriate treatment after exposure. Varicella vaccine
may be an important and worthwhile solution to the
problems of this disease, but it should not be given dur-
ing pregnancy.
Our series supports the findings of previous reviews
that emphasize the severity of chickenpox in pregnancy,
particularly the morbidity of varicella pneumonia. It also
confirms the association of chickenpox with premature
labor and delivery. The definition of varicella embry-
opathy may be too restrictive; congenital varicella may
be a more appropriate term. Programs for preventing
both maternal and fetal disease are the next logical step
in our approach to varicella in pregnancy.
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